FindTrial
Sign In

Talampanel

DRUG10 trials

Sponsors

Teva Branded Pharmaceutical Products R&D, Inc., National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health Clinical Center (CC)

Conditions

ALSAmyotrophic Lateral SclerosisAnaplastic AstrocytomaAnaplastic Mixed OligoastrocytomaAnaplastic OligodendrogliomaBrain and Central Nervous System TumorsDyskinesiasEpilepsy

Phase 1

Effects of Talampanel on Patients With Advanced Parkinson's Disease
CompletedNCT00036296
Teva Branded Pharmaceutical Products R&D, Inc.Dyskinesias, Movement Disorders, Parkinson Disease
Start: 2006-12-31End: 2007-02-28Updated: 2011-04-13
A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm
CompletedNCT00964730
Teva Branded Pharmaceutical Products R&D, Inc.Healthy
Start: 2009-10-31End: 2010-02-28Target: 135Updated: 2010-04-07

Phase 2

Multicenter Trial for Adults With Partial Seizures
CompletedNCT00034814
Teva Branded Pharmaceutical Products R&D, Inc.Epilepsy
Start: 2002-01-31End: 2006-01-31Updated: 2011-03-17
Effect of Talampanel (an AMPA Receptor Blocker) on Brain Activity
CompletedNCT00057460
National Institute of Neurological Disorders and Stroke (NINDS)Healthy
Start: 2003-04-30End: 2006-05-31Target: 25Updated: 2008-03-04
Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
TerminatedNCT00062504
Teva Branded Pharmaceutical Products R&D, Inc.Anaplastic Astrocytoma, Anaplastic Mixed Oligoastrocytoma, Anaplastic Oligodendroglioma +1
Start: 2003-07-31End: 2006-04-30Updated: 2011-05-23
Talampanel in Treating Patients With Recurrent High-Grade Glioma
CompletedNCT00064363
National Institutes of Health Clinical Center (CC)Brain and Central Nervous System Tumors
Start: 2003-06-30End: 2007-02-28Updated: 2012-03-08
Talampanel to Treat Parkinson's Disease
CompletedNCT00108667
National Institute of Neurological Disorders and Stroke (NINDS)Parkinson Disease
Start: 2005-04-30End: 2006-02-28Target: 40Updated: 2008-03-04
Safety and Efficacy of Talampanel in Glioblastoma Multiforme
CompletedNCT00267592
Teva Branded Pharmaceutical Products R&D, Inc.Glioblastoma Multiforme
Start: 2005-12-31End: 2011-02-28Updated: 2016-05-19
Talampanel for Amyotrophic Lateral Sclerosis (ALS)
CompletedNCT00696332
Teva Branded Pharmaceutical Products R&D, Inc.ALS
Start: 2008-09-30End: 2010-05-31Updated: 2011-10-21
Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)
TerminatedNCT00982150
Teva Branded Pharmaceutical Products R&D, Inc.Amyotrophic Lateral Sclerosis
Start: 2009-09-30End: 2010-06-30Updated: 2013-08-26